Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
A clinical trial is evaluating serum glycomics as prognostic and diagnostic biomarkers for recurrence of hepatocellular carcinoma in liver t…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial [Phase 4]
A Phase 4 randomized, double-blind trial evaluated the safety and efficacy of XSLJZ in advanced hepatocellular carcinoma patients previously…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure [Phase 2]
Phase 2 clinical trial evaluating nimotuzumab in combination with immune checkpoint inhibitors for advanced hepatocellular carcinoma after f…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Paediatric Hepatic International Tumour Trial [Phase 3]
This is an update on a pediatric Phase 3 international trial evaluating treatments for liver tumors. The study is currently active but not r…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT
A completed clinical trial update evaluating plasma biomarkers to predict response and toxicity in hepatocellular carcinoma patients treated…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation
The trial update describes research and potential application of a new clinical diagnosis and treatment system for HBV-related hepatocellula…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer [Phase 2]
A Phase 2 clinical trial evaluating chidamide in combination with sintilimab and bevacizumab as first-line therapy for advanced hepatocellul…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation [Phase 1, Phase 2]
A clinical trial update announces a Phase 1/Phase 2 study of FOLFOX plus lenvatinib as adjuvant therapy for hepatocellular carcinoma after l…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy [Phase 2]
Phase 2 clinical trial evaluating sequential transarterial chemoembolization (TACE) and stereotactic body radiation therapy (SBRT) followed …
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy [NA]
This update describes a clinical trial evaluating transcutaneous electrical acupoint stimulation (TEAS) for chronic pain and survival in pat…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update for Cadonilimab in combination with Lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellul…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC. [Phase 4]
Phase 4 clinical trial comparing triple versus dual adjuvant therapy after liver resection in hepatocellular carcinoma is currently recruiti…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC [Phase 2]
A Phase 2 clinical trial evaluating the combination of sintilimab, bevacizumab, and selective internal radiation therapy (SIRT) for non-rese…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma [Phase 4]
A Phase 4 clinical trial evaluating precision adjuvant therapy after surgery for hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Natural Killer (NK) Cell Therapy in Locally Advanced HCC [Phase 2]
A Phase 2 clinical trial evaluating natural killer (NK) cell therapy for locally advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma
A clinical trial evaluating AKR1B10 as a biomarker to guide interventional therapy for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion [Phase 3]
This is a Phase 3 trial evaluating postoperative adjuvant sintilimab in hepatocellular carcinoma with microvascular invasion. The study stat…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Impact of Hepatectomy on HCC Recurrence
This clinical trial evaluating whether hepatectomy affects recurrence in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis [Phase 2]
Phase II study evaluating moderate-dose hypofractionated radiotherapy combined with pembrolizumab for hepatocellular carcinoma with diffuse …
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating AK104 alone or in combination with lenvatinib for advanced Hepatocellular Carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
This is an update on a Phase 1/Phase 2 trial of AK104 plus lenvatinib in first-line advanced hepatocellular carcinoma. The study status is c…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma [NA]
A clinical trial sponsored by Taipei Veterans General Hospital in Taiwan is evaluating the use of ChatGPT to educate patients with early-sta…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study) [Phase 3]
Phase 3 trial investigating lenvatinib combined with transarterial chemoembolization (TACE) and camrelizumab for conversion to resection in …
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy [NA]
Results from the HistoSonics histotripsy system trial for liver tumors have been posted. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Study to Evaluate SHR-1210 in Subjects With Advanced HCC [Phase 2]
Phase 2 trial of SHR-1210 in advanced hepatocellular carcinoma (non-resectable) completed with results posted in 2024.